Mesenchymal stem cells (MSCs) are promising seed cells for neural regeneration therapy
owing to their plasticity and accessibility. They possess several inherent characteristics …

Innate immunity is part of the early response of the body to deal with tissue damage and
infections. Because of the early nature of the innate immune inflammatory response, this …

Stem cell transplantation, as a promising treatment for central nervous system (CNS)
diseases, has been hampered by crucial issues such as a low cell survival rate, incomplete …

Intracerebral hemorrhagic stroke (ICH) causes high mortality and morbidity with very limited
treatment options. Cell-based therapy has emerged as a novel approach to replace …

Neurogenesis occurs in the hippocampus of the developing and adult brain due to the
presence of multipotent stem cells and restricted precursor cells at different stages of …

Background Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs)
have been shown to prevent brain damage and improve neurocognition following …

Background: The convoluted pathophysiology of brain disorders along with penetration
issue of drugs to brain represents major hurdle that requires some novel therapies. The …

Background This study aimed to investigate the therapeutic effects of transplanting
neutrophin-3 (NT-3)-expressing bone marrow-derived mesenchymal stem cells (BMSCs) in …

The Prognostic Value of Serum Neuron Specific Enolase (NSE) and S100B Level in Patients of
Acute Spinal Cord Injury - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Objectives To investigate the safety and therapeutic efficacy of autologous olfactory
ensheathing cell (OEC) transplantation in cervical spinal cord injury (SCI). Methods Patients …